SCHEMBL31684766

SCHEMBL31684766

C=CC(=O)Nc1ccc(Nc2nc(Nc3cccc(N4CCN(C)CC4)c3)ncc2Cl)cc1Cl

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP3K7 O43318 4/20 0.73
SRC P12931 3/20 0.73
MAP2K1 Q02750 3/20 0.73
MAPK1 P28482 2/20 0.73
FGFR1 P11362 1/20 0.73
BTK Q06187 4/20 0.66
JAK3 P52333 8/20 0.66
EGFR P00533 7/20 0.64
JAK2 O60674 3/20 0.64
BLK P51451 3/20 0.64
BMX P51813 2/20 0.64
FLT3 P36888 3/20 0.63
ITK Q08881 2/20 0.61
JAK1 P23458 1/20 0.61
TTK P33981 1/20 0.61
TXK P42681 1/20 0.61
ALK Q9UM73 2/20 0.60
PLK4 O00444 1/20 0.60
GAK O14976 1/20 0.60
NUAK1 O60285 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28980998 1.00 MAP3K7 (0.73) MAP3K7SRCMAP2K1MAPK1FGFR1
SCHEMBL28980982 0.93 MAP3K7 (0.80) MAP3K7SRCMAP2K1MAPK1FGFR1
SCHEMBL31684777 0.93 MAP3K7 (0.80) MAP3K7SRCMAP2K1MAPK1FGFR1
SCHEMBL31684778 0.89 BTK (0.80) MAP3K7SRCMAP2K1MAPK1FGFR1
SCHEMBL28980968 0.89 BTK (0.80) MAP3K7SRCMAP2K1MAPK1FGFR1
SCHEMBL28980986 0.88 CCND3 (0.69) MAP3K7SRCMAP2K1MAPK1FGFR1
SCHEMBL31684756 0.88 CCND3 (0.69) MAP3K7SRCMAP2K1MAPK1FGFR1
SCHEMBL31684785 0.87 MAP3K7 (0.66) MAP3K7SRCMAP2K1MAPK1FGFR1
SCHEMBL28980978 0.87 MAP3K7 (0.66) MAP3K7SRCMAP2K1MAPK1FGFR1
SCHEMBL31684776 0.86 MAP3K7 (0.70) MAP3K7SRCMAP2K1MAPK1FGFR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4617261-A1 2,4,5-TRISUBSTITUTED PYRIMIDINE COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF Wenzhou Medical University (CN) 2025-09-17 EP claimed